Caribou Biosciences Inc (CRBU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Sales | 1,476 | 1,586 | 0 | 1,198 | 8,478 |
| Gross Profit | 1,476 | 1,586 | N/A | 1,198 | 8,478 |
| Operating Expenses | 17,440 | 14,761 | 0 | 9,427 | 10,733 |
| Operating Income | -15,964 | -13,175 | N/A | -8,229 | -2,255 |
| Interest Expense | 0 | 0 | 0 | 6 | 5 |
| Other Income | 1,653 | 16 | 0 | 89 | 338 |
| Pre-tax Income | -14,311 | -13,159 | 0 | -8,146 | -1,922 |
| Income Tax | 0 | 0 | N/A | -213 | -50 |
| Net Income Continuous | -14,311 | -13,159 | N/A | -7,933 | -1,872 |
| Net Income | $-14,311 | $-13,159 | $N/A | $-7,933 | $-1,872 |
| EPS Basic Total Ops | -1.39 | -1.39 | N/A | -0.93 | -0.22 |
| EPS Basic Continuous Ops | -1.39 | -1.39 | N/A | -0.93 | -0.22 |
| EPS Diluted Total Ops | -1.39 | -1.39 | N/A | -0.93 | -0.22 |
| EPS Diluted Continuous Ops | -1.39 | -1.39 | N/A | -0.93 | -0.22 |
| EBITDA(a) | $-15,734 | $-12,954 | $N/A | $-8,003 | $-2,255 |